Clinical trial

CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)

NCT00219973

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE3

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2010-04-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Venous Thromboembolismunresolved

Interventions

BemiparinDRUG

Sponsors & collaborators

Rovi Pharmaceuticals Laboratorieslead sponsor

Mapped research locations

MadridSpain1 Saint PetersburgRussia1 LisbonPortugal1 TimișoaraRomania1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00219973 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.